Oral or mandibular advancement devices – like the O2VentTM are emerging as an accepted alternative treatment for sleep-disordered breathing conditions with recent studies showing similar long-term health outcomes1. The recent Oventus clinical trial showed that 100 percent of patients experienced a significant reduction in snoring and an improvement in AHI with 82 percent of patients eliminating snoring completely and 76 percent of patients reducing their AHI by more than half2. Oventus are pleased to announce the first peer-reviewed clinical data was published at the AADSM 25th Anniversary Meeting in Denver in June 2016.
The early design of the O2VentTM has been used for some time in private clinical practice. Developed in 2013, Oventus conducted a pilot study on the design with promising results. After further refinement and in particular using 3D printing technology, the device has been improved to be more comfortable with a more compact device.
If you are interested in the O2Vent, call us to discuss your individual situation.
1. Sutherland, et. al, Oral Appliance Treatment for Obstructive Sleep Apnea: An Update. Journal of Clinical Sleep Medicine. February 15 2014.
2.Lavery D, Hart C et al. Safety and Efficacy of a Novel Oral Appliance in the Treatment of Obstructive Sleep Apnea. Journal of Dental Sleep Medicine Vol.4 No.3 July 2017